The Light and the Dark side of Maternal PKU: Single Centre Experience of Dietary Management and Emergency Treatment Protocol of Unplanned Pregnancies
Authors:
- Claudia GautieroCGClaudia Gautiero
- Iris ScalaISIris Scala
- Giulia EspositoGEGiulia Esposito
- Maria Rosaria CoppolaMCMaria Rosaria Coppola
- Nunzia CacciapuotiNCNunzia Cacciapuoti
- Mariagrazia FiscoMFMariagrazia Fisco
- Margherita RuoppoloMargherita Ruoppolo
- Pietro StrisciuglioPSPietro Strisciuglio
- Giancarlo ParentiGPGiancarlo Parenti
- Bruna GuidaBGBruna Guida
Preprint
- 6 March 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Maternal phenylketonuria syndrome (MPKUS) is the most serious pregnancy complication of women with phenylketonuria (PKU). High phenylalanine (Phe) levels are indeed embryotoxic for the fetus. A low-Phe diet started before conception and maintained throughout pregnancy ensures optimal blood Phe concentrations (120-360 μmol/L) and pregnancy outcome. Women with unplanned pregnancies are at higher risk of MPKUS and require a rapid and sustained reduction of blood Phe. In this retrospective study, we evaluated the effects of dietary intervention on Phe levels and on clinical parameters of the offspring at birth in a group of patients with PKU. We also describe the fetal outcome of unplanned and untreated PKU mothers. The cohort consisted of 13 patients for a total of 22 pregnancies: 16 successful pregnancies and 6 abortions. Pregnancies were divided into three groups: "Planned Pregnancies, PP (n=5)", "Unplanned Pregnancies, UP (n=6)" and "Unplanned and untreated Pregnancies UT (n=5)". Women in the UP group showed higher levels of Phe than women in the PP group especially during the first trimester. The offspring of the UP group showed no congenital malformations but lower median auxologic parameters at birth compared to PP, although not significantly different. The women in the UT group received the diagnosis of PKU after the birth of a MPKUS offspring. Low-Phe diet is critical to prevent MPKUS especially when started before conception or no later than 10th week of gestation. Intensive effort is necessary to avoid unplanned pregnancies and to identify undiagnosed PKU women at risk of MPKUS.Keywords
All Related Versions
- Version 1, 2025-03-06, Preprints
- Published version: Nutrients, 17 (6), 1048.
This publication has 28 references indexed in Scilit:
- Phenylalanine hydroxylase deficiency treatment and management: A systematic evidence review of the American College of Medical Genetics and Genomics (ACMG)Genetics in Medicine, 2023
- Impact of pregnancy planning and preconceptual dietary training on metabolic control and offspring's outcome in phenylketonuriaJournal of Inherited Metabolic Disease, 2022
- Maternal phenylketonuria in Turkey: outcomes of 71 pregnancies and issues in managementEuropean Journal of Pediatrics, 2019
- Undiagnosed phenylketonuria in parents of phenylketonuric patients, is it worthwhile to be checked?Molecular Genetics and Metabolism, 2013
- Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardationJournal of Inherited Metabolic Disease, 2012
- The transplacental transport of essential amino acids in uncomplicated human pregnanciesAmerican Journal of Obstetrics and Gynecology, 2009
- Finding the fertile woman with phenylketonuriaEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2008
- A practical approach to maternal phenylketonuria managementJournal of Inherited Metabolic Disease, 2007
- The International Study of Pregnancy Outcome in Women with Maternal Phenylketonuria: Report of a 12-year studyAmerican Journal of Obstetrics and Gynecology, 2000
- Rationale for the German recommendations for phenylalanine level control in phenylketonuria 1997European Journal of Pediatrics, 1999